Galapagos has reported early results from three studies of its salt inducible kinase (SIK) 2/3 inhibitor GLPG3970, the first candidate from its portfolio of SIK inhibitor compounds. GLPG3970 was ...
Mechelen, Belgium; 14 July 2021; 22.01 CET; regulated information – Galapagos NV (Euronext & Nasdaq: GLPG) reports topline results with GLPG3970 in three patient studies. GLPG3970, the first product ...
After talking up its anti-inflammatory therapies for years, Galapagos is switching gears to preclinical SIK inhibitors after the lead compound in the critical program delivered underwhelming midphase ...
Big Bet, the gripping new K-drama on Disney+ and Hulu about the rise and fall of a ruthless Korean casino mogul, returned in February for its second season. The gritty Korean crime drama—the most ...
Despite having a controversial grants recipient, the program that expressed its intent to proceed with the interview announced the participant's absence a day before the interview. This decision was ...
Park Seo Joon and Park Hyung Sik will be making a guest appearance on KBS 2TV’s “2 Days & 1 Night.” On November 23, the show announced the confirmation of their appearances. Park Seo Joon and Park ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback